Alterity Therapeutics Ltd Share Price Today: Live Updates & Key Insights
Alterity Therapeutics Ltd share price today is $4.51, up -3.2%. The stock opened at $4.54 against the previous close of $4.69, with an intraday high of $4.65 and low of $4.53.
Alterity Therapeutics Ltd Share Price Chart
Alterity Therapeutics Ltd
Alterity Therapeutics Ltd Share Price Performance
Alterity Therapeutics Ltd Institutional Holdings
Alterity Therapeutics Ltd Market Status
Alterity Therapeutics Ltd Fundamentals
Market Cap 85.01 M
PB Ratio 2.2425
PE Ratio 0.0
Enterprise Value 51.65 M
Total Assets 46.03 M
Volume 17932
Alterity Therapeutics Ltd Company Financials
About Alterity Therapeutics Ltd & investment objective
Company Information Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Organisation Biotechnology
Employees 9
Industry Biotechnology
CEO Dr. David A. Stamler M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Alterity Therapeutics Ltd FAQs
What is the share price of Alterity Therapeutics Ltd today?
The current share price of Alterity Therapeutics Ltd is $4.51.
Can I buy Alterity Therapeutics Ltd shares in India?
Yes, Indian investors can buy Alterity Therapeutics Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Alterity Therapeutics Ltd shares in India?
You can easily invest in Alterity Therapeutics Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Alterity Therapeutics Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Alterity Therapeutics Ltd.
Can I buy fractional shares of Alterity Therapeutics Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Alterity Therapeutics Ltd?
Alterity Therapeutics Ltd has a market cap of $85.01 M.
In which sector does Alterity Therapeutics Ltd belong?
Alterity Therapeutics Ltd operates in the Biotechnology sector.
What documents are required to invest in Alterity Therapeutics Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Alterity Therapeutics Ltd?
The PE ratio of Alterity Therapeutics Ltd is N/A and the PB ratio is 2.24.